HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
IL9R
interleukin 9 receptor
Chromosome X|Y · Xq28 and Yq12
NCBI Gene: 3581Ensembl: ENSG00000124334.20HGNC: HGNC:6030UniProt: Q01113
60PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Receptor
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
interleukin-9-mediated signaling pathwayplasma membraneinterleukin-9 receptor activityimmunoglobulin mediated immune responseneoplasmmyeloid sarcomainfectionexperimental autoimmune encephalomyelitis
✦AI Summary

IL9R (interleukin-9 receptor) is a cytokine receptor located in the pseudoautosomal region of the X and Y chrX|Y 1 that functions as a key mediator of IL-9 signaling in immune and stromal cells. As a plasma membrane receptor, IL9R binds IL-9 and activates JAK-STAT signaling pathways, particularly JAK1/JAK3-STAT1/STAT3/STAT4/STAT5, to regulate T cell differentiation, proliferation, and effector functions 234. IL9R plays critical roles in multiple disease contexts. In rheumatoid arthritis, IL9R-mediated signaling on CD4+ T cells sustains a pathogenic PU.1-IL9 positive feedback loop in Th9 cells that drives inflammatory activation 5. In acute myeloid leukemia, LSC-derived IL-9 signals through IL9R on CD4+ T cells to promote Th1 skewing and IFN-γ production, paradoxically enhancing LSC expansion 6. In atopic dermatitis, IL-9 signaling through IL9R on Th2 cells enhances IL-18-induced IL-13 and IL-22 secretion 2. Notably, IL9R+ CD8+ cytotoxic T cells characterize atopic dermatitis but are absent in chrX|Y nodular prurigo 7. In pregnancy, decreased placental IL9/IL9R expression impairs trophoblast proliferation and angiogenesis in preeclampsia 8. IL9R engineering in CAR T cells enhances anti-tumor efficacy through superior STAT signaling and memory differentiation 34.

Sources cited
1
IL9R (interleukin-9 receptor) is a cytokine receptor located in the pseudoautosomal region of the X and Y chrX|Y that functions as a key mediator of IL-9 signaling in immune and stromal cells.
PMID: 8666384
2
As a plasma membrane receptor, IL9R binds IL-9 and activates JAK-STAT signaling pathways, particularly JAK1/JAK3-STAT1/STAT3/STAT4/STAT5, to regulate T cell differentiation, proliferation, and effector functions , , .
PMID: 39521283
3
As a plasma membrane receptor, IL9R binds IL-9 and activates JAK-STAT signaling pathways, particularly JAK1/JAK3-STAT1/STAT3/STAT4/STAT5, to regulate T cell differentiation, proliferation, and effector functions , , .
PMID: 41274291
4
As a plasma membrane receptor, IL9R binds IL-9 and activates JAK-STAT signaling pathways, particularly JAK1/JAK3-STAT1/STAT3/STAT4/STAT5, to regulate T cell differentiation, proliferation, and effector functions , , .
PMID: 41274289
5
In rheumatoid arthritis, IL9R-mediated signaling on CD4+ T cells sustains a pathogenic PU.1-IL9 positive feedback loop in Th9 cells that drives inflammatory activation .
PMID: 39164066
6
In acute myeloid leukemia, LSC-derived IL-9 signals through IL9R on CD4+ T cells to promote Th1 skewing and IFN-γ production, paradoxically enhancing LSC expansion .
PMID: 38941612
7
Notably, IL9R+ CD8+ cytotoxic T cells characterize atopic dermatitis but are absent in chrX|Y nodular prurigo .
PMID: 37210042
8
In pregnancy, decreased placental IL9/IL9R expression impairs trophoblast proliferation and angiogenesis in preeclampsia .
PMID: 32329646
Disease Associationsⓘ20
neoplasmOpen Targets
0.10Suggestive
myeloid sarcomaOpen Targets
0.08Suggestive
infectionOpen Targets
0.06Suggestive
experimental autoimmune encephalomyelitisOpen Targets
0.06Suggestive
autoimmune diseaseOpen Targets
0.05Suggestive
common variable immunodeficiencyOpen Targets
0.04Suggestive
immunoglobulin A deficiency 2Open Targets
0.04Suggestive
severe combined immunodeficiency due to CARD11 deficiencyOpen Targets
0.04Suggestive
autoimmune lymphoproliferative syndromeOpen Targets
0.04Suggestive
autoimmune lymphoproliferative syndrome type 1Open Targets
0.04Suggestive
immune system diseaseOpen Targets
0.04Suggestive
type II hypersensitivity reaction diseaseOpen Targets
0.04Suggestive
combined immunodeficiency due to CTPS1 deficiencyOpen Targets
0.04Suggestive
allergic rhinitisOpen Targets
0.04Suggestive
Familial exudative vitreoretinopathyOpen Targets
0.04Suggestive
reticular dysgenesisOpen Targets
0.04Suggestive
immunodeficiency 18Open Targets
0.04Suggestive
Autosomal recessive systemic lupus erythematosusOpen Targets
0.04Suggestive
autosomal systemic lupus erythematosus type 16Open Targets
0.04Suggestive
immunodeficiency 25Open Targets
0.04Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
IL4Protein interaction100%IL6Protein interaction100%JAK3Protein interaction100%IL5Protein interaction100%IL3Protein interaction100%CSF2Protein interaction100%
Tissue Expression6 tissues
Lung
100%
Brain
19%
Liver
17%
Ovary
12%
Bone Marrow
0%
Heart
0%
Gene Interaction Network
Click a node to explore
IL9RIL4IL6JAK3IL5IL3CSF2
PROTEIN STRUCTURE
Preparing viewer…
PDB7OX5 · 3.09 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.20LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.96 [0.77–1.20]
RankingsWhere IL9R stands among ~20K protein-coding genes
  • #7,673of 20,598
    Most Researched60
  • #12,637of 17,882
    Most Constrained (LOEUF)1.20
Genes detectedIL9R
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis.
PMID: 37210042
J Allergy Clin Immunol · 2023
1.00
2
Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development.
PMID: 39164066
Ann Rheum Dis · 2024
0.90
3
IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion.
PMID: 38941612
Blood · 2024
0.80
4
Interleukin-9.
PMID: 8379467
Adv Immunol · 1993
0.70
5
IL-9 sensitizes human T
PMID: 39521283
J Allergy Clin Immunol · 2025
0.60